Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction
Pharmacology Research & Perspectives · 2025
DOI: 10.1002/prp2.70143 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Laura Patanè und 5 weiteren Autor:innen. Beteiligte Einrichtung: IBD-Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. Hauptthemen laut MEDLINE: Glucosephosphate Dehydrogenase Deficiency, Hemolysis, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Glucose‐6‐phosphate‐dehydrogenase (G6PD) deficiency is a heterogenous disorder that may lead to severe hemolytic events with the ingestion of fava beans and exposure to certain drugs. We report the first case of a 65‐year‐old male with Crohn's disease who developed a hemolytic crisis leading to hospitalization shortly after commencement of upadacitinib. An autoimmune condition was excluded but, as his family history was a positive for G6PD deficiency, very low levels of erythrocyte G6PD were detected. Upadacitinib was immediately discontinued with subsequent resolution of hemolysis. This case highlights the importance of rigorous pharmacological surveillance and suggests the need for further studies to clarify the pathogenetic mechanisms underlying this adverse reaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IBD-Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
- Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy.
ORCID-Profile: Laura Patanè
Zitieren
APA
Patanè, L., Costantino, G., Muscianisi, M., De Francesco, C., Viola, A., & Fries, W. (2025). Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70143
Vancouver
Patanè L, Costantino G, Muscianisi M, De Francesco C, Viola A, Fries W. Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70143
BibTeX
@article{Patan2025,
author = {Patanè, Laura and Costantino, Giuseppe and Muscianisi, Marco and De Francesco, Clara and Viola, Anna and Fries, Walter},
title = {Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction},
journal = {Pharmacology Research & Perspectives},
year = {2025},
doi = {10.1002/prp2.70143}
}
EUVIMED